XML 61 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangible Assets, Net (Tables)
 12 Months Ended
Dec. 31, 2011
Intangible Assets, Net [Abstract]  
Schedule Of Intangible Assets, Net
                 
    December 31,     December 31,  
    2011     2010  
In-process research and development acquired in Anchen Acquisition, net of accumulated
        amortization of $0 and $0		   $ 126,700     $ -  
Developed products acquired in Anchen Acquisition, net of accumulated amortization
        of $1,650 and $0		     83,550       -  
QOL Medical, LLC Asset Purchase Agreement, net of accumulated amortization of
        $12,540 and $7,980		     42,181       46,741  
Teva Pharmaceuticals, Inc. Asset Purchase Agreement, net of accumulated amortization
        of $1,255		     16,745       -  
Glenmark Generics Limited and Glenmark Generics, Inc. USA Licensing Agreement, net
        of accumulated amortization of $0		     15,000       15,000  
Synthon Pharmaceuticals, Inc. Asset Purchase Agreement, net of accumulated
        amortization of $0		     9,600       -  
Covenant not-to-compete acquired in Anchen Acquisition, net of accumulated
        amortization of $358 and $0		     8,542       -  
Teva Pharmaceuticals, Inc. License and Distribution Agreement, net of accumulated
        amortization of $0		     6,000       -  
Genpharm, Inc. Distribution Agreement, net of accumulated amortization of $9,748
        and $9,026		     1,085       1,807  
Trademark licensed from Bristol-Myers Squibb Company, net of accumulated
        amortization of $9,148 and $7,433		     852       2,567  
SVC Pharma LP License and Distribution Agreement, net of accumulated amortization
        of $3,034 and $2,525		     650       1,159  
MDRNA, Inc. Asset Purchase Agreement, net of accumulated amortization of $1,750
        and $770		     350       1,330  
BioAlliance Licensing Agreement, net of accumulated amortization of $1,399 and $559     -       19,441  
MonoSol Rx Licensing Agreement, net of accumulated amortization of $350 and $125     -       5,875  
Spectrum Development and Marketing Agreement, net of accumulated amortization of
        $25,000 and $24,254		     -       746  
Other intangible assets, net of accumulated amortization of $7,209 and $5,947     414       801  
    $ 311,669     $ 95,467  
Schedule Of Estimated Amortization Expense
         
    Estimated  
    Amortization  
    Expense  
2012   $ 37,194  
2013     23,640  
2014     23,487  
2015     19,149  
2016     32,650  
2017 and thereafter     175,549  
    $ 311,669